GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

When it comes to health, sometimes you have to start in the middle. "We believe in treating the whole person because the pelvis is literally the middle of the body," said Physical Therapist Erica ...

The Prostate Cancer Foundation (PCF) celebrated groundbreaking progress and innovation in the fight against prostate cancer at its 32nd Annual PCF Scientific Retreat, held October 23-25, 2025, in ...

In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone ...

We estimate the NHS could potentially save £millions annually by greater use of the generic version of abiraterone rather than using enzalutamide and apalutamide, the other treatments we recommend at ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Fast growth for recently label-expanded drugs fuelled Novartis’ Q3 performance, despite headwinds from generic competition.

A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

President Donald Trump is meeting face-to-face with Chinese leader Xi Jinping on Thursday, a chance for the leaders of the ...

Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions ...

Frailty threatens older individuals because it increases their vulnerability to detrimental health outcomes, such as falling, ...